News · 26 weeks40%
2025-12-212026-06-14
Mix090d
No activity.
Latest news
25 items- SECSEC Form 15-12G filed by Cyanotech Corporation15-12G - CYANOTECH CORP (0000768408) (Filer)
- SECAmendment: SEC Form SC 13E3/A filed by Cyanotech CorporationSC 13E3/A - CYANOTECH CORP (0000768408) (Subject)
- SECAmendment: SEC Form SC 13E3/A filed by Cyanotech CorporationSC 13E3/A - CYANOTECH CORP (0000768408) (Subject)
- SECSEC Form SC 13E3 filed by Cyanotech CorporationSC 13E3 - CYANOTECH CORP (0000768408) (Subject)
- SECSEC Form 10-Q filed by Cyanotech Corporation10-Q - CYANOTECH CORP (0000768408) (Filer)
- PRCyanotech Reports Financial Results for the Second Quarter of Fiscal 2026Cyanotech Corporation (OTCQB:CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter of fiscal year 2026, ended September 30, 2025. Commenting on the second quarter of fiscal year 2026 results, Cyanotech's President and Chief Executive Officer, Matthew K. Custer, said: "Our second quarter reflected continued momentum in both sales growth and profitability. Total sales increased 19.3% year-over-year, driven by higher bulk sales and strong performance in our online channels. "We also saw meaningful improvement in gross margin as our production volumes continued to increase, driving lower per
- INSIDERSEC Form 4 filed by CFO, VP Fin & Admin, Treasurer Miyashiro Jennifer A.S.4 - CYANOTECH CORP (0000768408) (Issuer)
- INSIDERSEC Form 3 filed by new insider Miyashiro Jennifer A.S.3 - CYANOTECH CORP (0000768408) (Issuer)
- INSIDERDirector Mulder David M was granted 50,000 units of Cyanotech Corporation Common Stock, increasing direct ownership by 33% to 203,468 units (SEC Form 4)4 - CYANOTECH CORP (0000768408) (Issuer)
- INSIDERDirector Vied David L was granted 50,000 units of Cyanotech Corporation Common Stock, increasing direct ownership by 29% to 225,138 units (SEC Form 4)4 - CYANOTECH CORP (0000768408) (Issuer)
- INSIDERDirector Davis Michael A / was granted 50,000 units of Cyanotech Corporation Common Stock (SEC Form 4)4 - CYANOTECH CORP (0000768408) (Issuer)
- SECCyanotech Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - CYANOTECH CORP (0000768408) (Filer)
- SECCyanotech Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events8-K - CYANOTECH CORP (0000768408) (Filer)
- SECSEC Form 10-Q filed by Cyanotech Corporation10-Q - CYANOTECH CORP (0000768408) (Filer)
- PRCyanotech Reports Financial Results for the First Quarter of Fiscal 2026Cyanotech Corporation (OTCQB:CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2026, ended June 30, 2025. Commenting on the first quarter of fiscal year 2026 results, Cyanotech's President and Chief Executive Officer, Matthew K. Custer, said: "While top-line revenue remained relatively flat compared to the prior year, I am encouraged by the meaningful improvement in both gross margin and net loss reduction. Our margin expansion, from 25.0% in the prior year to 30.5%, reflects the continuation of strong operational discipline and improved production efficiency." "We re
- INSIDERPresident and CEO Custer Matthew Keith converted options into 2,075 shares, increasing direct ownership by 44% to 6,754 units (SEC Form 4)4 - CYANOTECH CORP (0000768408) (Issuer)
- INSIDERVP, HR, Secretary Nordin Amy Beth converted options into 1,502 shares and covered exercise/tax liability with 525 shares, increasing direct ownership by 12% to 9,051 units (SEC Form 4)4 - CYANOTECH CORP (0000768408) (Issuer)
- INSIDERVP, Quality, Regulatory & Govt Johansen Jennifer M. converted options into 1,380 shares and covered exercise/tax liability with 518 shares, increasing direct ownership by 10% to 9,743 units (SEC Form 4)4 - CYANOTECH CORP (0000768408) (Issuer)
- INSIDERChief Scientific Officer Cysewski Gerald R converted options into 1,577 shares and covered exercise/tax liability with 592 shares, increasing direct ownership by 0.68% to 146,697 units (SEC Form 4)4 - CYANOTECH CORP (0000768408) (Issuer)
- INSIDERVP, Operations Jensen Glenn covered exercise/tax liability with 617 shares and converted options into 1,642 shares, increasing direct ownership by 4% to 27,110 units (SEC Form 4)4 - CYANOTECH CORP (0000768408) (Issuer)
- SECSEC Form DEF 14A filed by Cyanotech CorporationDEF 14A - CYANOTECH CORP (0000768408) (Filer)
- SECSEC Form 10-K filed by Cyanotech Corporation10-K - CYANOTECH CORP (0000768408) (Filer)
- PRCyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025Cyanotech Corporation (OTCQB Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter and fiscal year 2025, ended March 31, 2025. Commenting on the fiscal year results (changes shown vs. fiscal 2024), Cyanotech's President and Chief Executive Officer, Matthew K. Custer, said: "Fiscal 2025 was a year of meaningful progress for Cyanotech. Revenue grew 5%, gross margin improved by nearly 3 points and we reduced our operating loss by almost 45%." "Looking ahead, we remain cautious. Economic uncertainty, shifting demand and potential new tariffs could impact costs and global markets. W
- INSIDERSEC Form 4 filed by President and CEO Custer Matthew Keith4 - CYANOTECH CORP (0000768408) (Issuer)
- INSIDERSEC Form 4 filed by VP of Sales Brand Jennifer Kimberly4 - CYANOTECH CORP (0000768408) (Issuer)
CYAN FAQ
5 questionsWhat does Cyanotech Corporation do?
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a...Where does CYAN stock trade?
Cyanotech Corporation (CYAN) is listed on NASDAQ.What sector and industry is CYAN in?
Cyanotech Corporation operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What companies are similar to CYAN?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), RLX (RLX Technology Inc.). Compare CYAN side-by-side with any of them on Quantisnow.How can I track CYAN on Quantisnow?
Quantisnow aggregates Cyanotech Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CYAN to receive live email and push alerts on every new disclosure.